参麦注射液配合化疗治疗恶性肿瘤疗效观察  

Effects of shenmaiinjection Combined with the chemotheraty in the treatment of malignaut tumor

作　　者：陈曦[1] 黄晓娟[1] 宋健斌[1] 

机构地区：[1]哈尔滨242医院,150066

出　　处：《航空航天医药》2009年第2期69-70,共2页Aerospace Medicine

摘　　要：目的:评价中药参麦注射液联合化疗治疗晚期恶性肿瘤的疗效。方法:对48例晚期恶性者接受肿瘤化疗方案的病例进行分析,随机分成两组。对照组(22例)单纯化疗和治疗组(26例)参麦注射液联合化疗。结果:疗效比较:治疗组缓解率优于对照组,但无统计学意义(P>0.05)两组在临床症状改善、生活质量改善、毒副反应、外周白细胞及免疫功能变化方面治疗前后比较,治疗组优于对照组,比较有差异(P<0.05)。结论:参麦注射液联合化疗治疗晚期恶性肿瘤,可提高化疗疗效,但无统计学意义;在减轻化疗不良反应、改善临床症状、提高生活质量、提高免疫功能、保护骨髓等方面有较好的临床效果。Objcetive： To investigate the effects of shenmai injection combined with chemotherapy in the treatment of malignant tumor. Methods： We selected eases. Combined chemotherapy group and molapy group. The chemotherapy plans were according to different kinds of cancer and various types of pathology. Results： The combined ehemtherrapy group was obviously better than the chemotherapy group. Conclusions：

关 键 词：参麦注射液 恶性肿瘤 临床疗效 

分 类 号：R730.5[医药卫生—肿瘤]